تخطى إلى المحتوى / Skip to content

Try TabeebPlus fully for 7 days free!

Evidence Grade Bscreening

G8 — Geriatric 8 Screening

The Geriatric 8 (G8) screening tool is an 8-item validated instrument designed to identify older patients who may benefit from comprehensive geriatric assessment (CGA). It is widely used in geriatric oncology to detect frailty.

Patient Parameters

Enter the values below to calculate the score.

Has food intake declined over the past 3 months due to appetite loss, digestive problems, or chewing/swallowing difficulties?
Compared to other people of the same age, how does the patient consider their health status?

About

The G8 (Geriatric 8) screening tool was developed by the French National Geriatric Oncology Program to screen for frailty in older adults with cancer. It consists of 8 items covering: food intake decline due to digestive problems/decreased appetite/chewing or swallowing difficulties (0-3 points), weight loss in the past 3 months (0-3 points), mobility (0-2 points), neuropsychological problems including dementia or depression (0-2 points), BMI (0-3 points), number of prescription medications per day (0-1 point), self-rated health compared to peers (0-2 points), and age (0-1 point). Total scores range from 0 (most impaired) to 17 (least impaired). A score of ≤14 is considered abnormal and indicates the need for comprehensive geriatric assessment (CGA). The G8 has been validated in multiple international cohorts and demonstrates sensitivity of 76-92% for detecting frailty. The G8 is the most widely used geriatric screening tool in oncology and is recommended by the International Society of Geriatric Oncology (SIOG) and the American Society of Clinical Oncology (ASCO) guidelines for geriatric assessment in older adults with cancer.

Formula

Total = Food Intake (0-3) + Weight Loss (0-3) + Mobility (0-2) + Neuropsych (0-2) + BMI (0-3) + Meds (0-1) + Self-Rated Health (0-2) + Age (0-1). Max 17. ≤14 = abnormal.

The G8 total score is calculated by summing points from 8 items assessing different aspects of geriatric health. Each item has specific response categories with varying point values. Item 1: Has food intake declined due to appetite loss, digestive problems, or chewing/swallowing difficulties? (0 = severe decrease, 1 = moderate decrease, 2 = no decrease). Item 2: Weight loss in the past 3 months (0 = >3 kg loss, 1 = does not know, 2 = 1-3 kg loss, 3 = no loss). Item 3: Mobility (0 = bed/chair bound, 1 = able to get out of bed/chair but does not go out, 2 = goes out). Item 4: Neuropsychological problems (0 = severe dementia/depression, 1 = mild dementia/depression, 2 = no problems). Item 5: BMI (0 = <19, 1 = 19-21, 2 = 21-23, 3 = ≥23). Item 6: Number of medications (0 = ≥3, 1 = 0-2). Item 7: Self-rated health compared to peers (0 = not as good, 1 = does not know, 2 = as good). Item 8: Age (0 = ≥85, 1 = <85). A total score ≤14 indicates that the patient would benefit from comprehensive geriatric assessment.

Score Interpretation

The G8 is the most widely used geriatric screening tool in oncology, recommended by SIOG and ASCO guidelines for all older adults (≥70 years) with cancer. It identifies patients who would benefit from comprehensive geriatric assessment (CGA), which has been shown to improve treatment tolerance, reduce toxicity, and improve quality of life in older cancer patients. The G8 has a high negative predictive value (95%) for frailty, meaning a normal score reliably identifies patients who do not need CGA. The G8 takes approximately 5 minutes to complete and can be administered by any healthcare professional.

At Risk (Abnormal)0–14

Abnormal G8 score indicating need for comprehensive geriatric assessment (CGA).

Management: Refer for comprehensive geriatric assessment. Evaluate frailty, nutrition, polypharmacy, and functional status.

Normal15–17

Normal G8 score. No frailty detected on screening.

Management: Continue routine geriatric care. Encourage healthy aging practices.

Reference Ranges

PopulationNormal RangeNotes
Older adults (≥70 years)15-17 — NormalNo frailty detected. Continue routine care.
Older adults (≥70 years)0-14 — At RiskAbnormal. Comprehensive geriatric assessment recommended.
Dr. Ahmed Abdelrahman

Dr. Ahmed Abdelrahman

MD, MScInternal Medicine

Dr. Ahmed is a healthcare management consultant with over 15 years of experience in clinical practice and medical education.

View medical review board & editorial policy →

Example Calculation

A 78-year-old woman with recently diagnosed stage II colorectal cancer is being evaluated for treatment planning. G8 assessment: Food intake: moderate decrease due to chemotherapy-related nausea (1 point), Weight loss: 2 kg in past 3 months (2 points), Mobility: goes out independently (2 points), Neuropsych: no problems (2 points), BMI: 21.5 (2 points), Medications: 4 prescription medications (0 points), Self-rated health: not as good as peers (0 points), Age: <85 (1 point). Total G8 score = 1+2+2+2+2+0+0+1 = 10/17. This abnormal score (≤14) indicates the patient would benefit from comprehensive geriatric assessment before initiating cancer treatment to optimize outcomes and minimize toxicity.

Common Mistakes

Mistake

Using G8 as a substitute for comprehensive geriatric assessment (CGA)

Correction

G8 is a screening tool, not a comprehensive assessment. Abnormal G8 (≤14) triggers referral for CGA, not a diagnosis of frailty.

Mistake

Not knowing patient's weight loss amount and scoring as 0

Correction

If weight loss is unknown, score as 1 point ("does not know"). Do not default to 0 or 3. Weight estimation by family or records may help.

Frequently Asked Questions

What is comprehensive geriatric assessment (CGA)?
Comprehensive Geriatric Assessment (CGA) is a multidimensional, multidisciplinary process that evaluates an older person's medical, functional, cognitive, psychological, and social status. It typically involves a team including a geriatrician, nurse, pharmacist, physical therapist, occupational therapist, and social worker. CGA has been shown to improve outcomes including reduced hospitalizations, improved functional status, and better quality of life.
Who should be screened with G8?
The G8 is recommended for all older adults aged 70 years and above, particularly those being evaluated for cancer treatment or undergoing geriatric care. Many oncology guidelines recommend G8 screening for all patients aged 70+ at initial consultation.

References

  • Bellera CA, Rainfray M, Mathoulin-Pélissier S, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(8):2166-2172. PubMed
  • Soubeyran P, Bellera C, Goyard J, et al. Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study. PLoS One. 2014;9(12):e115060. PubMed
  • International Society of Geriatric Oncology (SIOG). SIOG 10 Priorities for Geriatric Oncology. SIOG; 2021.
Medical Disclaimer: This calculator is intended for use by healthcare professionals for educational and clinical decision support purposes only. It is not a substitute for professional clinical judgment.
Call Us
WhatsApp